-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$1.5050% Upside
Connect Biopharma Holdings Limited Frequently Asked Questions
-
What analysts cover Connect Biopharma Holdings Limited?
Connect Biopharma Holdings Limited has been rated by research analysts at Piper Sandler in the past 90 days.